ExpreS2ion Biotech Holding Balance Sheet Health
Financial Health criteria checks 4/6
ExpreS2ion Biotech Holding has a total shareholder equity of SEK60.9M and total debt of SEK275.0K, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are SEK74.3M and SEK13.3M respectively.
Key information
0.5%
Debt to equity ratio
kr275.00k
Debt
| Interest coverage ratio | n/a |
| Cash | kr57.60m |
| Equity | kr60.93m |
| Total liabilities | kr13.33m |
| Total assets | kr74.26m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: EXPRS2's short term assets (SEK68.7M) exceed its short term liabilities (SEK11.4M).
Long Term Liabilities: EXPRS2's short term assets (SEK68.7M) exceed its long term liabilities (SEK1.9M).
Debt to Equity History and Analysis
Debt Level: EXPRS2 has more cash than its total debt.
Reducing Debt: EXPRS2's debt to equity ratio has reduced from 11.1% to 0.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EXPRS2 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: EXPRS2 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 45.5% each year